Artificial Intelligence in Endoscopic Ultrasound
Launched by ORLANDO HEALTH, INC. · Aug 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new artificial intelligence (AI) system that aims to help doctors detect problems in the pancreas during a procedure called endoscopic ultrasound. This procedure allows doctors to see inside the body using a small camera. The goal of the study is to see if the AI can identify issues in the pancreas, such as pancreatic cancer or cysts, as accurately as a trained doctor.
If you are 18 years or older and are scheduled to undergo an endoscopic ultrasound, you may be eligible to participate in this study. Participants will have the opportunity to receive care as usual during their examination, while also helping to evaluate the effectiveness of this AI technology. The study is currently looking for participants, and everyone, regardless of gender, is welcome to join. Your involvement could contribute to improving how doctors diagnose and treat pancreatic conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Any patient undergoing endoscopic ultrasound examination
- Exclusion Criteria:
- • Age \< 18 years
About Orlando Health, Inc.
Orlando Health, Inc. is a comprehensive healthcare organization based in Orlando, Florida, dedicated to providing high-quality patient care through innovative clinical research and trials. As a leading academic medical center, Orlando Health integrates advanced medical practices with a commitment to improving health outcomes in the community. The organization engages in a wide range of clinical research initiatives, collaborating with healthcare professionals and researchers to advance medical knowledge and develop new therapies. With a focus on patient safety and ethical standards, Orlando Health strives to enhance the quality of life for patients through evidence-based practices and cutting-edge medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Shyam Varadarajulu, MD
Principal Investigator
Orlando Health, Digestive Health Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported